Literature DB >> 16710327

The trypanolytic factor of human serum.

Etienne Pays1, Benoit Vanhollebeke, Luc Vanhamme, Françoise Paturiaux-Hanocq, Derek P Nolan, David Pérez-Morga.   

Abstract

African trypanosomes (the prototype of which is Trypanosoma brucei brucei) are protozoan parasites that infect a wide range of mammals. Human blood, unlike the blood of other mammals, has efficient trypanolytic activity, and this needs to be counteracted by these parasites. Resistance to this activity has arisen in two subspecies of Trypanosoma brucei - Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense - allowing these parasites to infect humans, and this results in sleeping sickness in East Africa and West Africa, respectively. Study of the mechanism by which T. b. rhodesiense escapes lysis by human serum led to the identification of an ionic-pore-forming apolipoprotein - known as apolipoprotein L1 - that is associated with high-density-lipoprotein particles in human blood. In this Opinion article, we argue that apolipoprotein L1 is the factor that is responsible for the trypanolytic activity of human serum.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16710327     DOI: 10.1038/nrmicro1428

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  69 in total

1.  Rab28 function in trypanosomes: interactions with retromer and ESCRT pathways.

Authors:  Jennifer H Lumb; Ka Fai Leung; Kelly N Dubois; Mark C Field
Journal:  J Cell Sci       Date:  2011-11-18       Impact factor: 5.285

Review 2.  Arrest of the true culprit and acquittal of the innocent? Genetic revelations charge APOL1 variants with kidney disease susceptibility.

Authors:  Martin Zenker; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2010-11-16       Impact factor: 2.370

3.  Activation of endocytosis as an adaptation to the mammalian host by trypanosomes.

Authors:  Senthil Kumar A Natesan; Lori Peacock; Keith Matthews; Wendy Gibson; Mark C Field
Journal:  Eukaryot Cell       Date:  2007-09-28

4.  Three-dimensional cellular architecture of the flagellar pocket and associated cytoskeleton in trypanosomes revealed by electron microscope tomography.

Authors:  Sylvain Lacomble; Sue Vaughan; Catarina Gadelha; Mary K Morphew; Michael K Shaw; J Richard McIntosh; Keith Gull
Journal:  J Cell Sci       Date:  2009-03-19       Impact factor: 5.285

5.  Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations.

Authors:  Wen-Ya Ko; Prianka Rajan; Felicia Gomez; Laura Scheinfeldt; Ping An; Cheryl A Winkler; Alain Froment; Thomas B Nyambo; Sabah A Omar; Charles Wambebe; Alessia Ranciaro; Jibril B Hirbo; Sarah A Tishkoff
Journal:  Am J Hum Genet       Date:  2013-06-13       Impact factor: 11.025

Review 6.  The trypanosome flagellar pocket.

Authors:  Mark C Field; Mark Carrington
Journal:  Nat Rev Microbiol       Date:  2009-10-06       Impact factor: 60.633

7.  Evidence that low endocytic activity is not directly responsible for human serum resistance in the insect form of African trypanosomes.

Authors:  Senthil Ka Natesan; Lori Peacock; Ka Fai Leung; Wendy Gibson; Mark C Field
Journal:  BMC Res Notes       Date:  2010-03-05

Review 8.  Genetics of kidney failure and the evolving story of APOL1.

Authors:  David J Friedman; Martin R Pollak
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

9.  APOL1 variants change C-terminal conformational dynamics and binding to SNARE protein VAMP8.

Authors:  Sethu M Madhavan; John F O'Toole; Martha Konieczkowski; Laura Barisoni; David B Thomas; Santhi Ganesan; Leslie A Bruggeman; Matthias Buck; John R Sedor
Journal:  JCI Insight       Date:  2017-07-20

Review 10.  New insights on the risk for cardiovascular disease in African Americans: the role of added sugars.

Authors:  Karim R Saab; Jessica Kendrick; Joseph M Yracheta; Miguel A Lanaspa; Maisha Pollard; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.